#304: Prevention pays off...literally💰
The one-minute weekly healthtech roundup, by SomX
Hello healthtech friends. Another fun week in healthtech, plus I’m keen to get some info from you on the new NHS online for some analytical content, so I’m trying out the survey feature.
Enjoy. 🫡
News Bites 🥪
💰 Neko Health raises $700M for preventative healthcare: Healthtech’s really hotting up, honestly. Last week it was acquisitions, this week it’s the biggest ever raise from someone I’ve shaken the hand of and chatted to on the podcast. Hjalmar Nilsonne (and of course Daniel Ek of Spotify) have closed a $700M Series C for their preventative health outfit. If you don’t know what they do, it’s a <60 minute, £299 human-body-MOT with bloods and enough sensors to make you feel reassuringly surveilled. No full body MRI, they ‘only measure what’s actionable’ and are actively building bridges to the NHS to create and share data / insights. If you want a very deep dive on them and the prevention sector as a whole, I’ve written about preventative health and Neko specifically for Pigeon Insider (Part 1 - The Inverse Prevention Law and Part 2 - Can a private company drag the NHS toward prevention?). TLDR below*.
🚨 GPhC launches a fake-pharmacy crackdown as oral Wegovy lands: This is wild. The General Pharmaceutical Council’s kicked off a campaign urging anyone buying medicines online to check the pharmacy is actually registered, because in the last 12 months, criminals cloned 1/10 pharmacy websites to sell fake medicines. With oral semaglutide tablets arriving in UK pharmacies this month, chief exec Kathie Cashell’s warning is ‘a pill is far easier to counterfeit than an injection pen.’ As someone pretty clued up in healthtech, I didn’t realise any of this - 97% (!) of pharmacies surveyed already expect a spike in fake weight-loss products doing the rounds. The GPhC have a ten-point checklist, a register you can search in about thirty seconds, and a House of Commons roundtable behind the scenes trying to get platforms and enforcement rowing in the same direction.
💜 The Lowdown finds a home at Vira Health: More acquisition positivity. Alice Pelton’s nine-year-old contraception review platform (built after a dinner-table rant about the total absence of real data on what women actually experience on the pill) has been acquired by Vira Health who do healthcare support for employees. As the story goes, Alice rang Vira co-founder Andrea Berchowitz back in 2019 for advice, and now The Lowdown’s community, content and unfiltered-voices dataset fold into Vira’s proposition. As they say… ask for money and you’ll get advice, ask for advice and you might just get your women’s health platform acquired. Congrats to all.
🧬 Synnovis and SOPHiA GENETICS bring blood-test cancer diagnosis to the NHS: Under NHS England’s “blood test first” push, Synnovis is now running the MSK-ACCESS liquid biopsy test to detect actionable genomic mutations from a single blood draw. It’s already supporting roughly 400 lung and breast cancer patients a month, with the AI parsing circulating tumour DNA to flag treatment options up to two weeks faster than the old route. The plan is to scale to around 7,000 patients a year, close to 1/3 of all English lung and breast cancer tests. Remember… amongst all the ‘difficult to adopt’ stories in healthtech and software, biotech and devices continues to crack on and make impact.
⚖️ NICE decides healthtech deserves the same treatment as medicines: Expanding out of medicines, NICE is now doing its thing for devices, diagnostics and digital tools under the new National HealthTech Access Programme. That means a small set of high-impact technologies are going to get reimbursed and rolled out across the whole health service rather than living or dying by which trust you happen to live near. First through the door is a capsule sponge test for oesophageal cancer (delightfully named "pill on a string") and AI pathology tools for prostate and breast cancer. Let’s be honest, the fact we have postcode lottery is embarrassing so I’m all for anything that gets rid of it. Of course, a NICE yes has never guaranteed anyone buys anything, but let’s celebrate another positive step.
And finally…
😴 Your sleep tracker might be gaslighting you into a worse day: This is amazing. Researchers told participants they'd slept great or terrible (entirely made up), then ran them through cognitive tests. The ones that were told they'd slept badly performed worse. The ones that were told they'd slept brilliantly performed better. Slightly uncomfortable truth for the entire wearables industry… if people wake up feeling fine and glance at a bad sleep score, they’ll immediately feel awful and the world is hardly a better place. Slight caveat, it's a decade-old study that I only found this week from someone posting it on Instagram of all places, it’s small and cognition-specific, so ok let's not over-claim. But… as we’re under pressure to strap ever more sensors to ourselves and hand our mornings over to a number, the “nocebo” risk is very real and under-studied. I’d love to see a 2026 version of this experiment.
Pigeon insider is the upgraded newsletter for those of you that want deep research and to steal fantastic ideas to sound incredibly smart in front of everyone else.
This week’s is an exploration into “can we autonomously deliver primary care?” Because according to one company in the US… “fully autonomous primary care is ready to be launched.” Expect a deep dive into LLM capabilities, knowledge graphs and a critical look at how healthtech companies claim their AI capabilities.
Survey Time 📝
We’re trying out some audience participation this week.
I want to do some content on NHS Online for you all and I’m keen on your thoughts.
Three questions
Select 1 answer for each
It’s anonymous
What to listen to 🔊
Jessica and I chatted to Dr Mustafa Ghafouri, the GP-turned-builder we mentioned in this newsletter a couple of weeks back who’s behind hospitalwaits.co.uk, the epic tool that lets patients see which hospitals actually have the shortest waits for their procedure. Fascinating chat. He also talks really openly about how he built it, so if you want the 101 on Claude Code, I recommend queueing it up.
Niall Boyce and Chloe Wilson put AI triage and ambient scribes under proper scrutiny, including the risk that a tidy-looking symptom gets quietly downgraded by an algorithm.
Amsterdam's Philippe Habets (EvidenceHunt) argues OpenEvidence's EU and UK exit was less about the AI Act and more about an ad-and-data business model European clinicians were never going to trust. Spicy.
Rock Health's Megan Zweig on where the money is actually flowing in 2026, and why "strongest quarter since the pandemic" hides some very lumpy deal concentration. A useful counterweight if your funding bites are looking a touch euphoric.
Events 📅
Startup Lab x Specialist Briefings: AI Innovation vs. Regulation
🗓️ 22 July
🇬🇧 Hale House, London.
A panel on whether UK regulation is actually helping digital health and AI, or quietly strangling it. The eternal question, and one worth arguing about in person.
NXGN Season 2: The Future of Healthcare
🗓️ 30 July
🇬🇧 London.
The Season 2 opener from NXGN: a candid community evening on where healthcare is heading across the whole patient journey. Founders, clinicians and investors, minus the polished stage-speak.
HealthVC Summit 2026
🗓️ 2-3 September
🇨🇭 Zurich.
Two days connecting health investors and founders across Europe, China and Saudi Arabia. If you’re raising, this is where the cheque-writers gather.
Life Sciences Week 2026
🗓️ 21-25 September
🇬🇧 Birmingham.
Britain’s national life sciences week, pulling biotech, medtech, pharma, academia and investors into one place. A proper cross-sector convening rather than the usual echo chamber.
LSI Europe ‘26 Emerging Medtech Summit
🗓️ 28 September-1 October
🇪🇸 Grand Hyatt Barcelona.
Europe’s leading emerging-medtech investor summit, matching founders with VCs, PE and strategics. Sunny, well-connected, and squarely aimed at getting deals done.
Visit the SomX events page or subscribe to SomX’s events roundup for everything else.
Opportunity 🕵️♀️
AI Clinical Evaluation Workshop
📅 Thursday 13th August, 6:00–8:00pm (UK)
🇬🇧 Waterloo, London
Invite-only session for clinicians (apply at the link), chaired by Microsoft's Global CMO, who'll open with remarks on AI's shifting role in healthcare. You’ll independently put multiple AI tools through real-world clinical tasks using synthetic patient records, which feeds into a comparative study report earmarked for publication, with participants acknowledged, so it's a proper evaluation. If you're a clinician and curious how the tools actually stack up, very much worth applying.
Jobs 💰
🔎 Physician, Neko Health (New York): Spending $700M takes a village so no surprises that they’re hiring. Now in New York. The work is preventive medicine at volume, so reading structured scan results, catching things early, nudging members before symptoms turn up. Hard to think of a more talked-about clinic to practise in.
🏥 Clinical Lead, Concentric (Australia): Concentric’s UK digital consent platform (30,000+ clinicians, 40,000 patients a week) wants its first Australian clinical face. Someone who can win over sceptical hospital groups one demo at a time and provide feedback on what needs to change for Australian practice. Part-time is genuinely on the table if you want to keep one foot in clinic.
🔬 Senior Clinical Researcher & Data Scientist, Voy (UK): Voy wants a clinician who thinks like a data scientist, someone who can take messy real-world GLP-1, testosterone and menopause data and turn it into publication-grade evidence. If you've ever wanted your causal inference skills to actually move a pharma partnership rather than sit in a drawer, this is that job.
🇺🇸🗽 NXGN USA is growing
The US arm of the next-gen healthtech and biotech community is expanding its committee. If you’re an early-career founder, clinician or operator stateside and want a seat at the table to organise events and community (with a budget), message me and I’ll forward it onto Aakash and Athena.
📣 Want something in front of our 8,000+ readers?
You can break your news as the main story, feature a podcast, job or event... and we even have a few sponsorship packages to choose from...
We review everything editorially - if it is not right for our audience, we’ll let you know. Everything has to be valuable to this glorious community.
See you next week, Pigeon fans ✌🏼
James’ editor notes
* TLDR of the Pigeon Insider piece on the prevention space… I think progress in prevention is going to be made by those willing to tolerate the discomfort of several conflicting truths. Simultaneously, we have an obvious Inverse Prevention Law, no wide-spread, state-led prevention at scale, operational and technological private sector innovation attracting billions in funding, services like Neko that sit between an NHS Health Check and concierge medicine and two sides that can learn from and help each other if they collaborate in good faith. If you want to know more about Neko specifically, go for Part 2 of my deep dives.
Healthtech Pigeon is produced by SomX - the media-led communications and creative agency for healthcare. We help healthtech, biotech, pharma and public sector organisations tell sharper stories through strategy, PR, content, design, events and media production. Built by clinicians, scientists and creatives who know the space. Work with us.
Thank you for sharing the Concentric role in Aus pigeon :)